GeneralNeutralCrypto Briefing · 3h ago6/10
📰
Apotex seeks to raise C$1.2B in Toronto IPO, marking a major test for Canada’s public markets
Apotex, a major pharmaceutical company, is pursuing a C$1.2 billion IPO on the Toronto Stock Exchange, serving as a significant test for Canada's capital markets' ability to attract and retain large-cap listings. The offering could reshape investor confidence in Canadian public markets and influence future pharmaceutical sector investments.
